logo image
  • News
    • People Moves
    • Deal Wins
    • Demand Drivers
    • M&A and Funding
    • Financial Results
    • Technology
    • Academia
    • Industry News
    • Features
    • Machine Translation
    • — Divider —
    • Slator Pro
    • — Divider —
    • Press Releases
    • Sponsored Content
  • Data & Research
    • Research Reports & Pro Guides
    • Language Industry Investor Map
    • Real-Time Charts of Listed LSPs
    • Language Service Provider Index
  • Podcasts & Videos
  • Events
    • Design Thinking – February 2021
    • — Divider —
    • SlatorCon Coverage
    • Other Events
  • Directory
  • RFP Center
  • Jobs
MENU
  • News
    • People Moves
    • Deal Wins
    • Demand Drivers
    • M&A and Funding
    • Financial Results
    • Technology
    • Academia
    • Industry News
    • Features
    • Machine Translation
    • — Divider —
    • Slator Pro
    • — Divider —
    • Press Releases
    • Sponsored Content
  • Data & Research
    • Research Reports & Pro Guides
    • Language Industry Investor Map
    • Real-Time Charts of Listed LSPs
    • Language Service Provider Index
  • Podcasts & Videos
  • Events
    • Design Thinking – February 2021
    • — Divider —
    • SlatorCon Coverage
    • Other Events
  • Directory
  • RFP Center
  • Jobs

Advertise on Slator! Download the 2021 Online Media Kit Now

  • Slator Market Intelligence
  • Slator Advertising Services
  • Slator Advisory
  • Login
Search
Generic filters
Exact matches only
Loading Events
Advertisement
  • This event has passed.

Executive Roundtable: Compliance and Vendor Management in Clinical Trials

By Slator

Mar 30

| Singapore, Singapore

REGISTER
REGISTER

Outsourcing to and collaboration with third-parties in clinical trials requires a robust structure for successful vendor selection, contract design, quality monitoring and risk minimisation.

Join senior clinical operations and regulatory professionals at this exclusive roundtable discussion addressing the best strategies and tools for assessing, implementing and improving quality when partnering with clinical service providers.

The discussion will be lead by a senior Legal & Compliance Life Sciences professional, Maija Burtmanis, sharing her knowledge and experience in employing efficient and accurate strategies to mitigate legal and compliance risks.

Topics include

  • Overview of China’s CFDA self-inspection regime and outcome
  • Third-party vendor management: how far do you go in policing 3rd party CROs
  • Effectively avoiding significant protocol deviations and data integrity issues
  • Key aspects of quality assurance
  • Localization and specifics of QA
  • Validation and quality risk management
  • Data collection technology
  • Global standards and the use of such techniques as Risk Management, Quality-by-Design
  • Creating an effective personnel training system, metrics & total quality management system
  • Effective internal and external quality assurance auditing

The Speaker

Maija Burtmanis (LLB/BSc, LLM)

Maija is an Australian qualified senior Legal / Compliance Life Sciences Professional. She has worked as a senior lawyer and compliance professional for Pfizer, Novartis and Jn’J and has covered jurisdictions including Russia, Japan, China, India and the breadth of Asia Pacific.

During her career, Maija has worked on many aspects of legal / compliance “risk management” including the review and creation of policies which govern the conduct of foreign clinical trial programs; assistance with sensitive interactions involving patients, patient organisations and government representatives; education, training and advice on FCPA, Anti-Bribery, Code of Conduct and CIA requirements; Integrity and Ethics training; legal assistance with both internal and external investigations; corporate law strategic (M&A) projects; as well as liaison with international and local industry groups (such as PhRMA, IFPMA, AdvaMed & APEC) and healthcare professionals to advance key issues which impact the Life Sciences industry.

Recently Maija acquired an Anti-Corruption Summer Diploma from International Academy of Anti-Corruption (IACA) in Europe, and is also a member of Australian Institute of Company Directors (AICD).

Maija is passionate about the Life Sciences industry given its focus on innovation, patient safety and the development of state-of-the-art pharmaceutical and medical device products which are designed to improve life, longevity and good health.

Registration

This interactive roundtable discussion will be held over lunch (registration starts 11:30 a.m.; 12:00-2:00 p.m.) at the Fullerton Hotel, Singapore. Admission is free and strictly limited to senior professionals from both CROs and pharmaceutical companies (max. one per organization).

Who should attend this event:

  • Head of Procurement
  • Global Clinical Study Manager
  • Senior Director, Clinical Development Operations
  • Head Clinical Operations
  • Senior Regulatory Affairs Managers
  • Director, Clinical Operation
  • Head of Strategy and Operations
  • Chief Operating Officers
  • Country and Clinical Operations Director

This executive roundtable is sponsored by Lionbridge, one of the world’s largest providers of translation and languages services for the life sciences industry.

REGISTER

EVENT CATEGORIES

Life Sciences
SHARE

SUBSCRIBE TO THE SLATOR WEEKLY

Language Industry Intelligence
In Your Inbox. Every Friday

SUBSCRIBE

SlatorSweepSlatorPro
ResearchRFP CENTER

PUBLISH

PRESS RELEASEDIRECTORY LISTING
JOB ADEVENT LISTING

Bespoke advisory including speaking, briefings and M&A

SLATOR ADVISORY
Advertisement

Featured Reports

See all
Slator 2020 Language Industry M&A and Funding Report

Slator 2020 Language Industry M&A and Funding Report

by Slator

Slator 2021 Data-for-AI Market Report

Slator 2021 Data-for-AI Market Report

by Slator

Slator 2020 Medtech Translation and Localization Report

Slator 2020 Medtech Translation and Localization Report

by Slator

Pro Guide: Sales and Marketing for Language Service Providers

Pro Guide: Sales and Marketing for Language Service Providers

by Slator

Press Releases

See all
iDISC Awarded ISO 27001 Information Security Management Certification

iDISC Awarded ISO 27001 Information Security Management Certification

by iDISC

XTRF Launches a Bi-Monthly Free Networking Event for Localization Professionals

XTRF Launches a Bi-Monthly Free Networking Event for Localization Professionals

by XTRF

150 Million Words Translated: the German EU Council Presidency Translator Sets New Records

150 Million Words Translated: the German EU Council Presidency Translator Sets New Records

by Tilde

Upcoming Events

See All
  1. Memsource MT Post-Editing Pricing Models Webinar

    Pricing Models for MT Post-Editing Workshop

    by Memsource

    · February 3

    Hear a panel of innovative localization professionals share different approaches for MT post-editing pricing.

    More info FREE

Featured Companies

See all
Text United

Text United

Memsource

Memsource

Wordbank

Wordbank

Protranslating

Protranslating

Seprotec

Seprotec

Versacom

Versacom

SDL

SDL

Smartling

Smartling

Lingotek

Lingotek

XTM International

XTM International

Smartcat

Smartcat

Translators without Borders

Translators without Borders

STAR Group

STAR Group

memoQ Translation Technologies

memoQ Translation Technologies

Advertisement

Popular articles

Why Netflix Shut Down Its Translation Portal Hermes

Why Netflix Shut Down Its Translation Portal Hermes

by Esther Bond

The Slator 2020 Language Service Provider Index

The Slator 2020 Language Service Provider Index

by Slator

Top Language Industry Quotes of 2020

Top Language Industry Quotes of 2020

by Monica Jamieson

SlatorPod: The Weekly Language Industry Podcast

connect with us

footer logo

Slator makes business sense of the language services and technology market.

Our Company

  • Support
  • About us
  • Terms & Conditions
  • Privacy Policy

Subscribe to the Slator Weekly

Language Industry Intelligence
In Your Inbox. Every Friday

© 2021 Slator. All rights reserved.

Sign up to the Slator Weekly

Join over 13,000 subscribers and get the latest language industry intelligence every Friday

Your information will never be shared with third parties. No Spam.